WO2005091937A3 - Compositions useful for the treatment of microbial infections - Google Patents
Compositions useful for the treatment of microbial infections Download PDFInfo
- Publication number
- WO2005091937A3 WO2005091937A3 PCT/US2005/006761 US2005006761W WO2005091937A3 WO 2005091937 A3 WO2005091937 A3 WO 2005091937A3 US 2005006761 W US2005006761 W US 2005006761W WO 2005091937 A3 WO2005091937 A3 WO 2005091937A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microbial infections
- compositions useful
- treatment
- agents
- present
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 230000000813 microbial effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000002925 dental caries Diseases 0.000 abstract 1
- -1 e.g. Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/795,554 | 2004-03-04 | ||
US10/795,554 US7875598B2 (en) | 2004-03-04 | 2004-03-04 | Compositions useful for the treatment of microbial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005091937A2 WO2005091937A2 (en) | 2005-10-06 |
WO2005091937A3 true WO2005091937A3 (en) | 2006-03-30 |
Family
ID=35056693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/006761 WO2005091937A2 (en) | 2004-03-04 | 2005-03-02 | Compositions useful for the treatment of microbial infections |
Country Status (2)
Country | Link |
---|---|
US (1) | US7875598B2 (en) |
WO (1) | WO2005091937A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7875598B2 (en) | 2004-03-04 | 2011-01-25 | The Regents Of The University Of California | Compositions useful for the treatment of microbial infections |
CA2661634C (en) | 2006-09-06 | 2017-03-28 | The Regents Of The University Of California | Selectively targeted antimicrobial peptides and the use thereof |
CN101622271B (en) * | 2007-01-16 | 2014-08-27 | 加利福尼亚大学董事会 | Novel antimicrobial peptides |
WO2009090063A1 (en) * | 2008-01-16 | 2009-07-23 | Jado Technologies Gmbh | Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases |
US20110098495A1 (en) * | 2009-10-27 | 2011-04-28 | Chifu Huang | Compositions and methods of omega polyunsaturated fatty acids for the treatment of oral diseases |
KR101751486B1 (en) * | 2016-03-02 | 2017-06-28 | 광주과학기술원 | Composition for Enhancing BKCa Channel |
US20220096364A1 (en) * | 2020-09-28 | 2022-03-31 | The Procter & Gamble Company | Oral Care Compositions Comprising Prenylated Flavonoid |
CN112175884B (en) * | 2020-10-29 | 2022-04-15 | 北京农学院 | Lactobacillus plantarum SD26 and product and application thereof |
CN114432326A (en) * | 2022-03-15 | 2022-05-06 | 中国科学院昆明植物研究所 | Application of rhizoma paridis saponin in preparation of anti-candida albicans fluconazole drug-resistant strain product and anti-dermatophyte product |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000198724A (en) * | 1998-01-28 | 2000-07-18 | Pola Chem Ind Inc | Skin-beautifying preparation for external use for skin |
US6346267B1 (en) * | 2000-07-07 | 2002-02-12 | Wakunaga Of America Co., Ltd. | Composition and method for treatment of symptoms associated with insufficient estrogen production |
US20020102316A1 (en) * | 2000-12-01 | 2002-08-01 | Weissman Glenn H. | Composition and method for treating snoring |
CN1415301A (en) * | 2002-11-12 | 2003-05-07 | 蔡海德 | Compound recipe formula containing kurarinone prostaglandin E1 and aspirin, its preparation method and application |
US20030211185A1 (en) * | 2001-12-12 | 2003-11-13 | ALEXIS Brian | Natural, anti-bacterial, anti-virus, anti-herpes cream |
WO2004028519A1 (en) * | 2002-09-26 | 2004-04-08 | Mandom Corporation | Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5221571B2 (en) * | 1972-12-18 | 1977-06-11 | ||
US4324782A (en) * | 1974-01-28 | 1982-04-13 | Beck Lee R | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells |
US4150116A (en) * | 1978-02-21 | 1979-04-17 | Forsyth Dental Infirmary For Children | Immunization against dental caries with glucosyltransferase antigens |
ZA794413B (en) * | 1978-09-01 | 1980-08-27 | Us Government | Protection against dental caries |
US4250262A (en) * | 1979-12-14 | 1981-02-10 | Forsyth Dental Infirmary For Children | Method of preparing a purified glucosyltransferase |
HU187734B (en) * | 1981-06-19 | 1986-02-28 | The Secretary Of State For Social Services In Her Britannig Majesty's Government Of The United Kingdom Of Great Britain And Northen Ireland; Alexander Fleming House, Elephant And Castle,Gb | Process for the production of antigenic preparations against dental caries and of the pharmaceutical products containing tham as active substance |
US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
JPS6028937A (en) | 1983-07-25 | 1985-02-14 | Kitasato Inst:The | Noncariogenic antibody and composition |
JPS6038329A (en) | 1983-08-11 | 1985-02-27 | Lion Corp | Preventive for dental caries |
US4693888A (en) * | 1983-08-11 | 1987-09-15 | Lion Corporation | Caries-preventive composition |
JPH0641424B2 (en) * | 1984-11-06 | 1994-06-01 | ライオン株式会社 | Caries preventive agent |
US5057313A (en) * | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
US5352446A (en) * | 1986-03-25 | 1994-10-04 | Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals | Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans |
US5518721A (en) * | 1987-02-27 | 1996-05-21 | Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas Hospital | Antibodies against Streptococcus |
JP2641228B2 (en) * | 1988-01-22 | 1997-08-13 | 鐘紡株式会社 | Antibody, caries preventive agent containing the same as an active ingredient, and methods for producing the same |
US5281524A (en) * | 1988-01-22 | 1994-01-25 | Kanebo, Ltd. | Cell-associated glucosyltransferase from Streptococcus mutans serotype, c, e or f |
US5851527A (en) * | 1988-04-18 | 1998-12-22 | Immunomedics, Inc. | Method for antibody targeting of therapeutic agents |
JPH02177899A (en) | 1988-12-28 | 1990-07-10 | Nagase Sangyo Kk | Igd monoclonal antibody specifically reactive with streptococcus mutans |
AU626049B2 (en) * | 1989-05-29 | 1992-07-23 | Lion Corporation | Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop |
US5332567A (en) * | 1989-08-24 | 1994-07-26 | Immunomedics | Detection and treatment of infections with immunoconjugates |
US5314995A (en) * | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
GB9014932D0 (en) * | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
US6197299B1 (en) * | 1990-07-20 | 2001-03-06 | Pharmacia & Upjohn Ab | Antibody conjugates |
US5981726A (en) * | 1990-10-12 | 1999-11-09 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof |
WO1992022653A1 (en) | 1991-06-14 | 1992-12-23 | Genentech, Inc. | Method for making humanized antibodies |
US5646119A (en) * | 1991-11-01 | 1997-07-08 | Periodontix, Inc. | D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents |
JPH05227916A (en) | 1992-01-11 | 1993-09-07 | Kanebo Ltd | Dental caries preventing food |
ES2102007T3 (en) * | 1992-01-23 | 1997-07-16 | Merck Patent Gmbh | MONOMER AND DIMER ANTIBODY FRAGMENT FUSION PROTEINS. |
US5686075A (en) * | 1992-05-01 | 1997-11-11 | Forsyth Dental Infirmary For Children | Synthetic peptide vaccines for dental caries |
US5726293A (en) * | 1992-10-02 | 1998-03-10 | The General Hospital Corporation | Affinity purification methods involving imidazole elution |
JPH06122633A (en) | 1992-10-09 | 1994-05-06 | Lion Corp | Antibody having immunoactivity on streptococcus mutans and dental caries preventive |
DE69232604T2 (en) | 1992-11-04 | 2002-11-07 | City Of Hope Duarte | ANTIBODY CONSTRUCTS |
DE69528445D1 (en) * | 1994-12-12 | 2002-11-07 | Unilever Nv | Anti-microbial agent |
US6046037A (en) * | 1994-12-30 | 2000-04-04 | Hiatt; Andrew C. | Method for producing immunoglobulins containing protection proteins in plants and their use |
WO1997038669A1 (en) * | 1996-04-16 | 1997-10-23 | Novo Nordisk A/S | Compositions for the removal of dental plaque |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
US6183744B1 (en) * | 1997-03-24 | 2001-02-06 | Immunomedics, Inc. | Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
US6455031B1 (en) * | 1997-06-18 | 2002-09-24 | David G Davies | Methods and compositions for controlling biofilm development |
US5875798A (en) * | 1997-09-23 | 1999-03-02 | Advanced Medical Instruments, Inc. | Therapeutic toothpick for treating oral and systemic diseases |
US5874068A (en) * | 1997-12-08 | 1999-02-23 | Warner-Lambert Company | Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts |
US6303575B1 (en) | 1998-05-12 | 2001-10-16 | The Regents Of The University Of California | Indolicidin analogs and methods of using same |
US6673900B2 (en) * | 1999-11-04 | 2004-01-06 | University College London | Polypeptide hormone-phosphatonin |
AU756242B2 (en) | 1998-08-21 | 2003-01-09 | Regents Of The University Of California, The | Monoclonal antibodies specific for streptococcus mutans, and uses thereof |
US20040052814A1 (en) * | 1998-09-28 | 2004-03-18 | Wenyuan Shi | Fusion proteins for targeted delivery of antimicrobial peptides |
US6231857B1 (en) * | 1998-09-28 | 2001-05-15 | The Regents Of The University Of California | Antibodies to S. mutans and uses thereof |
US6309835B1 (en) * | 1999-05-27 | 2001-10-30 | Koninkiijke Philips Electronics N.V. | Methods for quantitating the efficacy of oral care products |
US7569542B2 (en) * | 1999-08-20 | 2009-08-04 | The Regents Of The University Of California | Anti-microbial targeting chimeric pharmaceutical |
US20020068066A1 (en) * | 1999-08-20 | 2002-06-06 | Wenyuan Shi | Method for the treatment and prevention of dental caries |
US20030143234A1 (en) * | 1999-08-20 | 2003-07-31 | Wenyuan Shi | Anti-microbial targeting chimeric pharmaceutical |
JP2003532698A (en) | 2000-05-10 | 2003-11-05 | プリンストン ユニバーシティ | Compounds and methods for regulating bacterial growth and pathogenesis |
US6492328B2 (en) * | 2000-06-28 | 2002-12-10 | The University Of Iowa Research Foundation | Novispirins: antimicrobial peptides |
EP1313506A1 (en) | 2000-08-24 | 2003-05-28 | Washington Dental Service | Immunologic method for the prevention of dental caries |
WO2002022686A2 (en) | 2000-09-15 | 2002-03-21 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer | Defensin-antigen fusion proteins |
AUPR575401A0 (en) * | 2001-06-18 | 2001-07-12 | Unisearch Limited | Method of causing sloughing |
IL145767A (en) * | 2001-10-04 | 2006-10-31 | Israel State | Microbicidal formulation comprising an essential oil or its derivatives |
US20040023254A1 (en) * | 2002-01-08 | 2004-02-05 | Fuhrmann Jeffry J. | Method to assess quorum sensing potential of microbial communities |
WO2003078576A2 (en) * | 2002-03-12 | 2003-09-25 | Nitto Denko Corporation | Vector for transfection of eukaryotic cells |
CN1649899A (en) * | 2002-05-03 | 2005-08-03 | 米列姆·贝尔罗吉克公司 | Connective tissue stimulating peptides |
US20030228379A1 (en) * | 2002-05-28 | 2003-12-11 | Wenyuan Shi | Herbs and herbal combinations useful for the treatment of microbial infections |
US7427408B2 (en) * | 2002-06-06 | 2008-09-23 | The Regents Of The University Of California | Quorum sensing and biofilm formation |
US7875598B2 (en) | 2004-03-04 | 2011-01-25 | The Regents Of The University Of California | Compositions useful for the treatment of microbial infections |
-
2004
- 2004-03-04 US US10/795,554 patent/US7875598B2/en not_active Expired - Fee Related
-
2005
- 2005-03-02 WO PCT/US2005/006761 patent/WO2005091937A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000198724A (en) * | 1998-01-28 | 2000-07-18 | Pola Chem Ind Inc | Skin-beautifying preparation for external use for skin |
US6346267B1 (en) * | 2000-07-07 | 2002-02-12 | Wakunaga Of America Co., Ltd. | Composition and method for treatment of symptoms associated with insufficient estrogen production |
US20020102316A1 (en) * | 2000-12-01 | 2002-08-01 | Weissman Glenn H. | Composition and method for treating snoring |
US20030211185A1 (en) * | 2001-12-12 | 2003-11-13 | ALEXIS Brian | Natural, anti-bacterial, anti-virus, anti-herpes cream |
WO2004028519A1 (en) * | 2002-09-26 | 2004-04-08 | Mandom Corporation | Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
CN1415301A (en) * | 2002-11-12 | 2003-05-07 | 蔡海德 | Compound recipe formula containing kurarinone prostaglandin E1 and aspirin, its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
US7875598B2 (en) | 2011-01-25 |
US20060135498A1 (en) | 2006-06-22 |
WO2005091937A2 (en) | 2005-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003099110A3 (en) | Herbs and herbal combinations useful for the treatment of microbial infections | |
WO2005091937A3 (en) | Compositions useful for the treatment of microbial infections | |
WO2004062625A3 (en) | Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease | |
WO2005032471A3 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2006086562A3 (en) | Phenylazetidinone derivatives | |
WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
WO2005102392A3 (en) | Combinations for treating hiv infection | |
WO2005004802A3 (en) | N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2005018545A3 (en) | Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2005004803A3 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | |
NO20053855D0 (en) | 1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases. | |
WO2005013892A3 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
WO2005051914A8 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
GEP20094834B (en) | Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections | |
EP2192901A4 (en) | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | |
WO2006034001A3 (en) | Methods of treating hiv infection | |
SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
EP1638938A4 (en) | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases | |
PL1654253T3 (en) | Substituted 3-pyrrolidin-indole derivatives | |
DE60122015D1 (en) | TREATMENT OF AFFECTIVE DISORDERS BY COMBINED EFFECT OF A NICOTINE RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
WO2007030708A3 (en) | Antimicrobial adzymes and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |